Prevalence and Treatment of Chronic Lymphocytic Leukaemia (Cll) In Germany: An Analysis of Sickness Funds
Jörg Tomeczkowski(Janssen (Germany)), Christoph Tapprich(Johnson & Johnson (Germany)), Jochen Fleischmann(Janssen (Germany)), M Leisten(Janssen (Germany)), C. Khuen(Janssen (Germany)), Haydar Metin(TU Wien)
Cited by 4
Related Papers
Cyclosporine A and Mycophenolate Mofetil vs Cyclosporine A and Methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings
|Bone Marrow Transplantation|2005|81
Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes
|Experimental Hematology|2008|58
The costs of schizophrenia and predictors of hospitalisation from the statutory health insurance perspective
|Health Economics Review|2012|42
Burden of illness of follicular lymphoma and marginal zone lymphoma
|Annals of Hematology|2018|32
Phase <scp>II</scp> study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: <scp>DSMM XI</scp> trial
|British Journal of Haematology|2017|30